Menu
Back to User profile » Dr Stefano Petruzzelli
Papers published by Dr Stefano Petruzzelli:
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA
Singh D, Fabbri LM, Vezzoli S, Petruzzelli S, Papi A
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:531-546
Published Date: 28 February 2019
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal
Vanfleteren L, Fabbri LM, Papi A, Petruzzelli S, Celli B
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3971-3981
Published Date: 12 December 2018
Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
Siddiqui SH, Pavord ID, Barnes NC, Guasconi A, Lettis S, Pascoe S, Petruzzelli S
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3669-3676
Published Date: 6 November 2018
The efficacy of extrafine beclomethasone dipropionate–formoterol fumarate in COPD patients who are not "frequent exacerbators": a post hoc analysis of the FORWARD study
Singh D, Vezzoli S, Petruzzelli S, Papi A
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3263-3271
Published Date: 3 November 2017
Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide
Singh D, Corradi M, Spinola M, Papi A, Usmani OS, Scuri M, Petruzzelli S, Vestbo J
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2917-2928
Published Date: 6 October 2017